UChicago scientists develop a new approach to study snoRNAs

Dynamic, reversible modifications of DNA and RNA regulate how genes are expressed and transcribed, which can influence cellular processes, disease development, and overall organismal health.

SciSparc signs patent license deal with Polyrizon for pain therapy

SciSparc will earn royalties from the commercialisation of the pain therapy. Credit: Wasan Tita/Shutterstock. Israel-based pharmaceutical company SciSparc has signed an exclusive patent licence agreement

August 19, 2024

After deal about-face and a spinout, Maze assembles $115M Series D

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 4, 2024

Certain gut microbes may be linked to skeletal health

There is growing evidence that a relative abundance of certain gut microbes may be related to skeletal health, according to a new study published in

September 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.